Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2004 Feb;89(2):121–124. doi: 10.1136/adc.2002.018655

Outcome of non-invasive positive pressure ventilation in paediatric neuromuscular disease

S Katz 1, H Selvadurai 1, K Keilty 1, M Mitchell 1, I MacLusky 1
PMCID: PMC1719799  PMID: 14736624

Abstract

Background: Non-invasive positive pressure ventilation (NPPV) has a beneficial effect on nocturnal hypoventilation and hospitalisation rates in adults with static or slowly progressive neuromuscular disease and respiratory failure. Its role in children affected with similar disease processes, however, remains unclear.

Aims: To investigate the impact of NPPV on hospitalisations and sleep related respiratory parameters in children with neuromuscular disease.

Methods: Fifteen children (mean age 11.7, range 3.4–17.8 years) diagnosed with neuromuscular disease who had been started on nocturnal NPPV and had at least one year of follow up since the initiation of such therapy were studied. Patients served as their own controls and comparison was made of the years preceding and following the initiation of NPPV.

Results: Children spent 85% fewer days in hospital (mean pre-NPPV 48.0 days, mean post-NPPV 7.0 days) and 68% less days in intensive care after initiation of NPPV (mean pre-NPPV 12.0 days, mean post-NPPV 3.9 days). Sleep study parameters including number of desaturations, apnoea-hypopnoea index and transcutaneous pCO2 levels improved after initiation of NPPV.

Conclusions: NPPV can decrease hospitalisations for children with neuromuscular disease and improves sleep related respiratory parameters. A prospective study is now needed to further delineate the role of NPPV in this population of children.

Full Text

The Full Text of this article is available as a PDF (175.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach J. R., O'Brien J., Krotenberg R., Alba A. S. Management of end stage respiratory failure in Duchenne muscular dystrophy. Muscle Nerve. 1987 Feb;10(2):177–182. doi: 10.1002/mus.880100212. [DOI] [PubMed] [Google Scholar]
  2. Barbé F., Quera-Salva M. A., de Lattre J., Gajdos P., Agustí A. G. Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest. 1996 Nov;110(5):1179–1183. doi: 10.1378/chest.110.5.1179. [DOI] [PubMed] [Google Scholar]
  3. Baydur A., Layne E., Aral H., Krishnareddy N., Topacio R., Frederick G., Bodden W. Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review. Thorax. 2000 Jan;55(1):4–11. doi: 10.1136/thorax.55.1.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boys A., Farrell M., Taylor C., Marsden J., Goodman R., Brugha T., Bebbington P., Jenkins R., Meltzer H. Psychiatric morbidity and substance use in young people aged 13-15 years: results from the Child and Adolescent Survey of Mental Health. Br J Psychiatry. 2003 Jun;182:509–517. doi: 10.1192/bjp.182.6.509. [DOI] [PubMed] [Google Scholar]
  5. Guilleminault C., Philip P., Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry. 1998 Aug;65(2):225–232. doi: 10.1136/jnnp.65.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hukins C. A., Hillman D. R. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2000 Jan;161(1):166–170. doi: 10.1164/ajrccm.161.1.9901057. [DOI] [PubMed] [Google Scholar]
  7. Khan Y., Heckmatt J. Z., Dubowitz V. Sleep studies and supportive ventilatory treatment in patients with congenital muscle disorders. Arch Dis Child. 1996 Mar;74(3):195–200. doi: 10.1136/adc.74.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lechtzin N., Weiner C. M., Clawson L. A fatal complication of noninvasive ventilation. N Engl J Med. 2001 Feb 15;344(7):533–533. doi: 10.1056/NEJM200102153440718. [DOI] [PubMed] [Google Scholar]
  9. Niranjan V., Bach J. R. Noninvasive management of pediatric neuromuscular ventilatory failure. Crit Care Med. 1998 Dec;26(12):2061–2065. doi: 10.1097/00003246-199812000-00042. [DOI] [PubMed] [Google Scholar]
  10. Padman R., Lawless S. T., Kettrick R. G. Noninvasive ventilation via bilevel positive airway pressure support in pediatric practice. Crit Care Med. 1998 Jan;26(1):169–173. doi: 10.1097/00003246-199801000-00034. [DOI] [PubMed] [Google Scholar]
  11. Reardon W., Newcombe R., Fenton I., Sibert J., Harper P. S. The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch Dis Child. 1993 Feb;68(2):177–181. doi: 10.1136/adc.68.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Robert D., Willig T. N., Leger P., Paulus J. Long-term nasal ventilation in neuromuscular disorders: report of a consensus conference. Eur Respir J. 1993 Apr;6(4):599–606. [PubMed] [Google Scholar]
  13. Tzeng A. C., Bach J. R. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest. 2000 Nov;118(5):1390–1396. doi: 10.1378/chest.118.5.1390. [DOI] [PubMed] [Google Scholar]
  14. Zerres K., Rudnik-Schöneborn S., Forrest E., Lusakowska A., Borkowska J., Hausmanowa-Petrusewicz I. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997 Feb 27;146(1):67–72. doi: 10.1016/s0022-510x(96)00284-5. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES